There is still a lot of work from IMU's end. I don't think any pharma company would put in to buy IMU at the current stage that it is at. There are numerous companies out there all vying to be bought out with different ranges of treatments/medicines/vaccines you name it. The Phase 3 Trial will be very important especially the HERVaxx PD1 combo. If that has favourable results i believe that heads will turn. It just depends when that is. These things again take time.
I take comfort that in the medical team however and their credentials. It's a slow burn. Who knows what the parameters of this Phase 3 Trial entails. Because they are trialling HERVaxx / PD1 for the first time is this really a phase 1 initiative? I don't know.
Charting Only., page-235
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 3.8¢ | 3.7¢ | $270.7K | 7.251M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 949810 | 3.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.8¢ | 2277658 | 11 |
View Market Depth
| Last trade - 16.10pm 26/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
